Compare OGN & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | FLNG |
|---|---|---|
| Founded | 1923 | 2006 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | 2019 |
| Metric | OGN | FLNG |
|---|---|---|
| Price | $13.38 | $29.57 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $11.40 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 5.0M | 448.5K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | 0.60% | ★ 9.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | $2.14 |
| P/E Ratio | $24.28 | ★ $19.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $21.72 |
| 52 Week High | $13.48 | $33.40 |
| Indicator | OGN | FLNG |
|---|---|---|
| Relative Strength Index (RSI) | 74.68 | 33.06 |
| Support Level | $10.05 | $28.62 |
| Resistance Level | $13.46 | $30.84 |
| Average True Range (ATR) | 0.05 | 0.82 |
| MACD | -0.22 | -0.35 |
| Stochastic Oscillator | 47.50 | 10.48 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The company's fleet consists of several LNG carriers on the water, and all of its vessels are of the latest generation equipped with two-stroke propulsion. Its fleet consists of M-type, Electronically Controlled, Gas Injection (MEGI) LNG carriers and Generation X Dual Fuel (X-DF) LNG carriers, offering improvements in fuel efficiency and thus also carbon footprint compared to the older steam and four-stroke propelled ships. The company has one reportable segment: vessel operations, which generates revenue from the chartering of vessels to customers.